Your browser doesn't support javascript.
loading
Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.
Julg, Boris; Sok, Devin; Schmidt, Stephen D; Abbink, Peter; Newman, Ruchi M; Broge, Thomas; Linde, Caitlyn; Nkolola, Joseph; Le, Khoa; Su, David; Torabi, Julia; Pack, Melissa; Pegu, Amarendra; Allen, Todd M; Mascola, John R; Burton, Dennis R; Barouch, Dan H.
Afiliação
  • Julg B; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Sok D; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Schmidt SD; The Scripps Research Institute, La Jolla, California, USA.
  • Abbink P; Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA.
  • Newman RM; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Broge T; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Linde C; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Nkolola J; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Le K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Su D; The Scripps Research Institute, La Jolla, California, USA.
  • Torabi J; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Pack M; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Pegu A; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Allen TM; Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA.
  • Mascola JR; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Burton DR; Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA.
  • Barouch DH; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
J Virol ; 91(20)2017 10 15.
Article em En | MEDLINE | ID: mdl-28768869
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Infecções por HIV / Síndrome de Imunodeficiência Adquirida dos Símios / HIV-1 / Vírus da Imunodeficiência Símia / Anticorpos Neutralizantes / Anticorpos Monoclonais Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Infecções por HIV / Síndrome de Imunodeficiência Adquirida dos Símios / HIV-1 / Vírus da Imunodeficiência Símia / Anticorpos Neutralizantes / Anticorpos Monoclonais Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos